205 related articles for article (PubMed ID: 34662000)
1. The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo-controlled, clinical trial.
Badrfam R; Mostafavi SA; Khaleghi A; Akhondzadeh S; Zandifar A; Farid M; Mohammadian Khonsari N; Mohammadi MR
Brain Behav; 2021 Nov; 11(11):e2394. PubMed ID: 34662000
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of vitamins B1 and B6 as an adjunctive therapy to lithium in bipolar-I disorder: A double-blind, randomized, placebo-controlled, clinical trial.
Zandifar A; Mousavi S; Schmidt NB; Badrfam R; Seif E; Qorbani M; Mehrabani Natanzi M
J Affect Disord; 2024 Jan; 345():103-111. PubMed ID: 37866735
[TBL] [Abstract][Full Text] [Related]
3. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
4. A Randomized, Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents with Acute Bipolar Mania.
Mousavi SY; Khezri R; Karkhaneh-Yousefi MA; Mohammadinejad P; Gholamian F; Mohammadi MR; Zeinoddini A; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):494-500. PubMed ID: 28409660
[TBL] [Abstract][Full Text] [Related]
5. Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.
Akhondzadeh S; Mohajari H; Reza Mohammadi M; Amini H
BMC Psychiatry; 2003 Jun; 3():7. PubMed ID: 12816549
[TBL] [Abstract][Full Text] [Related]
6. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
Bowden CL; Grunze H; Mullen J; Brecher M; Paulsson B; Jones M; Vågerö M; Svensson K
J Clin Psychiatry; 2005 Jan; 66(1):111-21. PubMed ID: 15669897
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double-blind, placebo-controlled trial.
Abedini T; Hosseyni R; Ghannadi F; Moghaddam HS; Ardakani MK; Talaei A; Akhondzadeh S
Psychiatry Clin Neurosci; 2022 Oct; 76(10):505-511. PubMed ID: 35737597
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of spironolactone as adjunctive therapy to sodium valproate in bipolar-I disorder: A double-blind, randomized, placebo-controlled clinical trial.
Zandifar A; Badrfam R; Gholamian F; Shafiee A
Brain Behav; 2023 Dec; 13(12):e3313. PubMed ID: 37933420
[TBL] [Abstract][Full Text] [Related]
10. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam as an Adjunctive Treatment for Mania: A Double-Blind, Randomized, Placebo-Controlled Trial.
Keshavarzi A; Sharifi A; Jahangard L; Soltanian A; Brühl AB; Ahmadpanah M; Brand S
Neuropsychobiology; 2022; 81(3):192-203. PubMed ID: 34979513
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.
Machado-Vieira R; Soares JC; Lara DR; Luckenbaugh DA; Busnello JV; Marca G; Cunha A; Souza DO; Zarate CA; Kapczinski F
J Clin Psychiatry; 2008 Aug; 69(8):1237-45. PubMed ID: 18681754
[TBL] [Abstract][Full Text] [Related]
14. Influence of adjuvant clonidine on mania, sleep disturbances and cognitive performance - Results from a double-blind and placebo-controlled randomized study in individuals with bipolar I disorder during their manic phase.
Ahmadpanah M; Pezeshki R; Soltanian AR; Jahangard L; Dürsteler KM; Keshavarzi A; Brand S
J Psychiatr Res; 2022 Feb; 146():163-171. PubMed ID: 34990968
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L
Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial.
Arabzadeh S; Ameli N; Zeinoddini A; Rezaei F; Farokhnia M; Mohammadinejad P; Ghaleiha A; Akhondzadeh S
Bipolar Disord; 2015 Sep; 17(6):606-14. PubMed ID: 26291962
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
18. The effect of vitamin B6 on cognition.
Malouf R; Grimley Evans J
Cochrane Database Syst Rev; 2003; (4):CD004393. PubMed ID: 14584010
[TBL] [Abstract][Full Text] [Related]
19. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder.
Weiser M; Burshtein S; Gershon AA; Marian G; Vlad N; Grecu IG; Tocari E; Tiugan A; Hotineanu M; Davis JM
Bipolar Disord; 2014 Jun; 16(4):441-7. PubMed ID: 24712840
[TBL] [Abstract][Full Text] [Related]
20. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
